Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome

Written By CCRG

Lavienraj Premraj, Nivedha V. Kaanapali, Jack Briggs, Stella M. Seal, Denise Battaglini, Jonathon Fanning, Jacky Suen, Chiara Robb, John Fraser, Sung-Min Cho Journal of Neurological Sciences DOI 10.1016/j.jns.2022.120162

Abstract: Neurological and neuropsychiatric symptoms that persist or develop three months after the onset of COVID-19 pose a significant threat to the global healthcare system. These symptoms are yet to be synthesized and quantified via meta-analysis. To determine the prevalence of neurological and neuropsychiatric symptoms reported 12 weeks (3 months) or more after acute COVID-19 onset in adults.

CCRG
Previous

Beneficial Effect of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019
Next

Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension